Chattem Chemicals, Inc. is licensed by the DEA to manufacture Schedule 1-5 controlled
substances in its API business unit and is inspected regularly by the FDA for compliance with
Good Manufacturing Practice. CCI has deep roots in the pharmaceutical industry. From our
beginnings in novel aluminum chemistries for antacids to the current production
of controlled substances, we have breadth of experience to meet a
variety of needs and applications.
In our Performance Additives business unit, the core aluminum alkoxide
technology that was responsible
for our early history was also found to be useful in other applications. For
nearly 40 years, CCI has been producing these aluminum-based products for the
ink, paint, grease, and petroleum industries to control the viscoelastic
properties of different systems.
In 2004, Chattem recognized an unmet market need in the surfactants area. The
Dow Chemical Co had made the decision to shut down its operations in Nashua, New Hampshire
that housed its Hamposyltm product lines and proprietary production process. CCI entered into
negotiations with Dow, eventually bought the equipment and technical package, and rebuilt the
plant in Chattanooga. Surfactants have been on a steady upward growth path since opening again in
April of 2005, and is now an all-important fourth business unit for the company.
CCI's glycine business unit offers products serving a wide variety of
applications. Our cGMP-compliant,
dedicated facility is the clear choice when product quality is the leading
consideration. With capabilities to control critical process parameters,
glycine produced by CCI is a market leader for custom specifications and
packaging solutions.
